Synfacts 2024; 20(02): 0193
DOI: 10.1055/s-0043-1763861
Innovative Drug Discovery and Development

Enantioselective Indole C3 Oxidation

Rezensent(en):
Dirk Trauner
,
Michael D. Zott
Li S, Liu X, Tung C.-H, Liu L. * Shandong University, Jinan, P. R. of China
Late-Stage Chemo- and Enantioselective Oxidation of Indoles to C3- Monosubstituted Oxindoles.

J. Am. Chem. Soc. 2023;
145: 27120-27130
DOI: 10.1021/jacs.3c11742.
 

Significance

Indole cores are found in a range of natural products and pharmaceuticals featuring a wide variety of bioactivities. Substitution of the 2- and 3-positions can dramatically affect the properties of the indole. While oxindoles with 3,3-disubstitution can be accessed by numerous methods, synthetic approaches to chiral 3-monosubstituted oxindoles are limited. One major challenge is the ease of racemization, since the 3-position is alpha to the amide carbonyl as well as benzylic. Liu et al. demonstrate a simple catalytic protocol for accessing these desirable substitution patterns with high ee (>90%, often 99%) and in only one step from common 3-substituted indoles.


#

Comment

To achieve the one-step synthesis of chiral, monosubstituted 3-oxindoles directly from 3-indoles, the authors envisioned an enantioselective epoxidation and a 2,3-hydride migration sequence. From a screen of known asymmetric epoxidation catalysts, sharpless-type titanium catalysts were found to exhibit the best performance; subsequent ligand optimization found the salan family of ligands to be optimal. Up to gram scale, enantiomeric excesses were routinely >97% ee. The protocol tolerates a range of sensitive functional groups (thiophenes, furans, amides, alkynes), and as such, late-stage functionalization of several drug analogues was possible.


#
#

Publikationsverlauf

Artikel online veröffentlicht:
16. Januar 2024

© 2024. Thieme. All rights reserved

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany